OncLive· @OncLive · X·· 8 days agoScore60
Body · original
@BalazsHalmosMD and @DylanFortman preview 14 lung cancer abstracts at #ESMO26, including DeLLphi-305 (LBA3), Krascendo 1 (LBA5), SAFFRON (LBA6), OptiTROP-Lung06 (LBA66), and PERSEE (2614O) @MontefioreNYC @EinsteinMed @UMich @myESMO #lcsm https://t.co/sLUzxhTULk https://t.co/blwwSYaxS4
Heat 2 · 1 like · 0 replies · 1 repost
Conference abstracts
2614ONCT04547504
2614ORead the abstract →NCT04547504NCT04547504matched by - **标题 / Title：** PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %
- **标题 / Title：** PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %Read the abstract →Source: OncLive · x.com